ModifiedColorado Rocky Mountain Health PlansPolicy CS136.R

Enteral Nutrition (Oral and Tube Feeding)

Defines medical necessity, coverage, and coding for enteral nutrition products (oral and tube feeding), including standard and specialized nutrient formulas and medical foods, for Colorado Rocky Mountain Health Plans members; excludes certain state-specific policies listed.

Policy Summary

PayerColorado Rocky Mountain Health Plans

PolicyEnteral Nutrition (Oral and Tube Feeding)

Policy CodePolicy CS136.R

Change TypeUpdated clinical evidence and referencesprior version archived

Effective DateMay 1, 2026

Next Review DateN/A

Key ActionObtain prior authorization per InterQual criteria for tube feeding and verify benefits and documentation for medical foods or specialized formulas.

SourceLink

POLICY UPDATE CHANGES

Updated Description of Services, Clinical Evidence, and References sections to reflect the most current information; previous policy version CS136.Q archived.

InterQualInterQual referenced

Inborn errorsInborn errors highlighted

Multiple B-codesHCPCS codes listed

Not coveredNot generally covered list

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

Tube Feeding (InterQual-based) Coverage

Enteral Nutrition by Tube Feeding is medically necessary when InterQual CP criteria are met.

Tube feeding medical necessity: Enteral nutrition administered by tube feeding (e.g., nasogastric, gastrostomy, or jejunostomy) is medically necessary in certain circumstances per InterQual CP: Durable Medical Equipment, Enteral and Parenteral Nutrition Therapy.InterQual criteria

See InterQual criteria referenced in policy for full logic.

Oral Specialized Nutrient Formula (Medical Food) Coverage

Specialized Nutrient Formula administered orally is medically necessary when ALL of the following are met:

Oral specialized formula criteria: A physician or advanced practitioner prescribes/supervises the formula; the condition is chronic and expected to last an undetermined or prolonged period; adequate nutrition cannot be achieved by dietary adjustment; the product is a Medical Food specially formulated for the specific condition; and the individual has one of the listed qualifying conditions (inborn errors of metabolism; CKD stages 2–5 or on dialysis for individuals <24 months; Crohn disease; severe malabsorption syndrome such as cystic fibrosis, short bowel syndrome, or intestinal failure; malnutrition or imminent risk of severe adverse outcomes without therapy; severe food allergies including eosinophilic gastrointestinal diseases, FPIES, or food protein–induced allergic proctocolitis that would cause life‑threatening reactions or malnourishment if untreated; or gastroesophageal reflux with failure to thrive in children).All conditions must be met

Refer to Benefit Considerations for coverage limitations and exclusions.

Covered indications for medical foods, specialized formulas, and therapeutic diets

Covered when clinical indication and guideline-recommended rationale are documented

PKU medical foods or specialized protein substitutes: Diagnosis of PAH deficiency (PKU) with documented need for a PHE‑restricted diet or medical food; documentation of prior metabolic control monitoring (plasma PHE) and nutrition assessment; selection of medical food (amino acid–based or glycomacropeptide‑based) justified by tolerance, adherence, or clinical judgment; protein equivalent dosing for infants/children should follow guideline recommendations.see guidelines

Systematic reviews support initiating a low‑PHE diet at diagnosis; RCT evidence on long‑term equivalence of specific products is limited.

Classical galactosemia in infants: Suspected classical galactosemia in an infant with compatible clinical features — immediate initiation of a galactose‑restricted formula (for example, soy‑based, casein hydrolysate, or elemental formula) should be documented without awaiting confirmatory testing.immediate

Per GalNet recommendations.

Guideline-aligned coverage considerations

Coverage may be considered when clinical criteria aligned with specialty society guidance are met:

Eosinophilic Esophagitis (EoE) dietary therapy

Diet options: Elemental (amino acid–based) formula OR empiric six‑food elimination diet OR allergy testing–based elimination diet per clinician decision and patient factorsN/A
Choice should reflect guideline strength, patient age, tolerance, and prior treatment response.

Malnutrition and enteral/oral nutrition support: Patient meets accepted criteria for malnutrition or at‑risk status per consensus definitions and requires nutrition support.Diagnosis based on >=2 characteristics in adults or pediatric z‑score/weight‑loss/velocity thresholds per guidance

Use ASPEN/Academy consensus indicators to identify malnutrition and determine need for oral, enteral, or parenteral support.

The policy distinguishes between standard oral formulas and specialized nutrient formulas (medical foods). Standard formulas and self-prepared or "self-blenderized" oral formulas are generally not covered unless specific exceptions apply. The policy explicitly lists items generally not covered, including standard formula for oral intake and self-blenderized formulas for oral intake, as well as related products such as commercial food thickeners and enteral formula additives when used orally.

This section does not provide an exhaustive list of exclusions; rather, coverage decisions rely on documented clinical indications and adherence to guideline-based criteria. For specialized nutrient formulas or medical foods, coverage requires documentation that the product is prescribed under physician or advanced practitioner supervision and that dietary adjustment alone cannot meet nutritional needs. Absence of guideline-supported indication or appropriate monitoring may justify denial under the plan's benefit terms.

The FDA definition and regulatory description of a medical food are provided for informational purposes only. Being labeled or marketed as a medical food under the FDA/Orphan Drug Act does not by itself establish medical necessity or guarantee coverage; applicable benefit contract and clinical justification must still be met.

Unless an exception applies per federal, state, or contractual requirements, the policy treats standard oral formula and the items enumerated in the benefit considerations list as generally not covered. Examples include standard oral formula, self-blenderized oral feeds, commercial thickeners, oral enteral additives, electrolyte-containing oral replacement fluids, and formulas intended for mild or moderate food allergies.

The clinical evidence summary identifies areas with limited high-quality randomized controlled trial data—for example, diet initiation and the optimal timing for relaxing dietary restrictions in PKU. The excerpt does not include explicit investigational (NMN) statements for every use; instead, it highlights evidence gaps that may affect authorization decisions when guideline-based indications or monitoring are not documented.

Coverage is not automatic solely because a product meets the FDA definition or is marketed as a medical food. The policy requires that the product meet the plan's clinical necessity criteria and that documentation align with relevant guidelines and the member's benefit contract before coverage will be approved.

Applicable Codes and Assessment Thresholds

Applicable HCPCS/Revenue CodesHCPCS

B4100	Food thickener, administered orally, per oz.
B4102	Enteral formula, for adults, used to replace fluids and electrolytes (e.g., clear liquids), 500 ml = 1 unit.
B4103	Enteral formula, for pediatrics, used to replace fluids and electrolytes (e.g., clear liquids), 500 ml = 1 unit.
B4104	Additive for enteral formula (e.g., fiber).
B4149	Enteral formula, manufactured blenderized natural foods with intact nutrients, includes proteins, fats, carbohydrates, vitamins, and minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unit.
B4150	Enteral formula, nutritionally complete with intact nutrients, includes proteins, fats, carbohydrates, vitamins, and minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unit.
B4152	Enteral formula, nutritionally complete, calorically dense (>= 1.5 kcal/ml) with intact nutrients, includes proteins, fats, carbohydrates, vitamins, and minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unit.
B4153	Enteral formula, nutritionally complete, hydrolyzed proteins (amino acids and peptide chain), includes fats, carbohydrates, vitamins, and minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unit.
B4154	Enteral formula, nutritionally complete, for special metabolic needs, excludes inherited disease of metabolism, includes altered composition of proteins, fats, carbohydrates, vitamins and/or minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unit.
B4155	Enteral formula, nutritionally incomplete/modular nutrients, includes specific nutrients, carbohydrates (e.g., glucose polymers), proteins/amino acids (e.g., glutamine, arginine), fat (e.g., medium chain triglycerides) or combination, administered through an enteral feeding tube, 100 calories = 1 unit.

1–10 of 20

1/2

Malnutrition assessment thresholds (ASPEN/Academy)

Adult malnutrition diagnosisRequires >=2 characteristics per ASPEN/Academy consensus (e.g., inadequate energy intake, weight loss, loss of muscle mass, loss of subcutaneous fat, localized or generalized fluid accumulation, diminished functional status); use adult criteria for clinical decision-making

Pediatric z-score thresholds (single data point)Weight‑for‑height or BMI‑for‑age z score: mild = -1 to -1.9; moderate = -2 to -2.9; severe = ≤ -3; length/height‑for‑age severe = -3

Pediatric weight‑loss/velocity thresholds (two or more data points)Weight gain velocity (<2 yrs): mild <75% of expected; moderate <50%; severe <25% of expected; Weight loss (2–20 yrs): mild = 5% body weight; moderate = 7.5%; severe = 10%

MUAC (mid‑upper arm circumference) thresholdsMUAC z scores: mild = -1 to -1.9; moderate = -2 to -2.9; severe = ≤ -3 — use as primary indicator when single data point available

Use in coverage decisionsDocument malnutrition using these thresholds to support need for oral supplements, specialized formulas, or enteral nutrition per guideline-aligned coverage considerations

Provider Actions, Prior Authorization, and Documentation

Prior Authorization

InterQual-based Prior Authorization for Tube Feeding

Prior authorization is required for enteral nutrition administered by tube feeding. Coverage and medical necessity determinations for tube-fed enteral nutrition follow InterQual CP: Durable Medical Equipment, Enteral and Parenteral Nutrition Therapy criteria; providers must submit InterQual documentation or equivalent clinical information to support necessity.

Applies to nasogastric, gastrostomy, and jejunostomy tube feeding
Attach InterQual decision support output or detailed clinical notes when submitting prior authorization requests

Prior Authorization

Prior Authorization: Medical Food and Elemental Formula Indications

Prior authorization is required for medical foods and elemental/amino acid formulas when used for specific, guideline-supported indications. Requests must document the clinical indication, prior dietary and medical-food trials, and rationale for the chosen product (e.g., PKU, inborn errors of metabolism, severe food allergies with failure to thrive, short bowel syndrome, severe malabsorption).

Indications: inborn errors of metabolism (PKU, MSUD, urea cycle disorders, etc.), severe eosinophilic gastrointestinal disease/EoE, severe food allergy with failure to thrive, short bowel/intestinal failure, certain pediatric CKD cases under dietitian oversight
Document prior use and response to extensively hydrolyzed formulas before amino acid–based formula unless severe disease/failure to thrive

Documentation Required

Verify Benefits and Prior Authorization

Verify member benefits and prior authorization requirements before initiating therapy. Benefit coverage is governed by the member's federal, state, and contractual plan terms which may impose additional limits or exclusions not in this policy.

Check member-specific benefits for medical food/formula coverage, quantity limits, age restrictions, and network requirements
If plan requires prior authorization, obtain approval before dispensing to avoid denials

Billing Rule

Claims Guidance When Oral Criteria Are Not Met

Claims for specialized formulas may be denied when oral criteria are not met; ensure claims reflect the route of administration (oral vs tube) and the clinical justification that meets coverage criteria.

Specialized formula for oral intake is generally covered only when oral criteria in the policy are met; otherwise, it is not covered
Standard formulas, self-blenderized formulas, and commercial thickeners for oral intake are generally not covered

Denial Risk

Evidence Limitations May Affect Authorization

Evidence limitations may affect authorization decisions. For some conditions (e.g., PKU dietary thresholds, timing for diet relaxation), high-quality randomized controlled trial evidence is limited; authorization may be denied if documentation does not link the requested product to expected clinical benefit.

Provide objective measures (labs, growth parameters, documented intolerance) to support medical necessity when evidence is limited
Requests lacking adequate clinical rationale or objective monitoring data may be declined

Note

FDA Approval Is Not Sole Basis for Coverage

FDA approval or regulatory status is informational only and is not, by itself, a basis for coverage. Medical foods are regulated as foods and not drugs; coverage decisions reference benefit terms and clinical necessity rather than FDA status.

Do not rely on FDA marketing status alone to justify coverage; supply clinical documentation that aligns with benefit language
Reference applicable benefit contract language when asserting coverage based on product classification

Documentation Required

Required Medical Supervision and Condition Documentation

Medical supervision and documentation are required. Medical foods and specialized enteral nutrition must be used under physician or advanced practitioner supervision with evidence of ongoing medical evaluation and follow-up.

Prescribing clinician must be a physician, nurse practitioner, physician assistant, or certified specialist as allowed by plan
Include evidence of ongoing follow-up visits and supervision in the medical record

Documentation Required

Suggested Documentation for Medical Nutrition Therapy

Suggested documentation to support medical nutrition therapy authorizations: include diagnosis, prior dietary and formula trials, objective response measures, and a monitoring plan with follow-up.

Diagnosis with clinical rationale linking the condition to the need for the specific medical food/formula
History of prior nutrition interventions (diet changes, trial of extensively hydrolyzed formula) and documented clinical response
Objective data: growth charts, weight/height percentiles, lab results (e.g., plasma PHE for PKU), stool studies, inflammatory markers as applicable
Monitoring and follow-up plan: frequency of clinician/dietitian visits, laboratory monitoring, and criteria for continuation or discontinuation

Documentation Required

Documentation and Benefit-Check Requirement

When making coverage decisions, reference federal, state, or contractual benefit requirements and document clinical justification with citations to applicable guidelines and evidence.

If federal or state mandates require coverage for a specific condition or product, follow those requirements and document the governing authority
Cite relevant clinical guidelines (ACMG, ESPGHAN, NASPGHAN, AAP) in the authorization request when applicable

Step Therapy

Preferred Stepwise Dietary Management

Preferred stepwise dietary management should be documented and followed when applicable: consider partial/whole-food exclusion diets (e.g., CDED for Crohn disease) or empiric elimination diets for EoE before advancing to elemental formulas when clinically appropriate.

For Crohn disease, document trials of CDED plus partial enteral nutrition or exclusive enteral nutrition as indicated by guidelines
For EoE, document trials of empiric elimination diets or six-food elimination prior to amino acid–based formula unless severe disease or failure to thrive

Step Therapy

Recommended Step-up Dietary Approaches

Recommended step-up approaches: in infants with severe reflux or suspected milk-protein driven disease, trial extensively hydrolyzed formulas first and escalate to amino acid–based formulas if symptoms persist or for failure to thrive or severe allergy.

Extensively hydrolyzed formula trial for 2–4 weeks before amino acid formula except in severe presentations
Amino acid–based formulas are indicated for persistent symptoms, failure to thrive, multiple food eliminations, or severe complex gastrointestinal food allergies

Definitions

Inborn Errors of Metabolism

DefinitionInborn Errors of Metabolism are disorders causing a block in a metabolic pathway leading to clinically significant consequences (examples: phenylketonuria, maple syrup urine disease, homocystinuria, methylmalonic acidemia, propionic acidemia, isovaleric acidemia, glutaric aciduria type I, tyrosinemia types I and II, and urea cycle disorders)

Clinical implicationThese conditions create distinctive nutritional requirements that often necessitate specialized dietary management or medical foods

Common examples referencedPhenylketonuria (PKU), maple syrup urine disease, urea cycle disorders, tyrosinemia types I and II

Medical Food (enteral use under physician supervision)

Core definitionA Medical Food is a specially formulated product for oral or enteral (tube) feeding, intended for the specific dietary management of a disease or condition with distinctive nutritional requirements and to be used under physician supervision

Key criteriaMust be specially formulated/processed (not a natural food), intended for patients who cannot meet needs by normal diet modification, provide nutrition support modified for the disease, and be used under medical supervision (21 CFR 101.9(j)(8))

Regulatory noteMedical foods are regulated as foods (not drugs) by the FDA; labeling and medical‑supervision expectations are part of the definition

Specialized Nutrient Formula

DefinitionSpecialized Nutrient Formula: a formula produced to meet unique nutrient needs for specific disease conditions

Intended useFormulated to address disease‑specific nutrient alterations that cannot be met by standard formulas or dietary modification

Form factorMay be provided orally or by enteral tube feeding depending on patient need and supervision

GMP‑MFs (glycomacropeptide medical foods) in PKU

What GMP‑MFs areGlycomacropeptide medical foods (GMP‑MFs) are medical foods using glycomacropeptide as the primary protein source for dietary management of PKU

Trial evidenceRandomized crossover trial (Ney et al., 2016) with 30 participants (ages 15–49) compared GMP‑MFs versus amino‑acid medical foods (AA‑MFs); GMP‑MFs had higher acceptability, improved GI symptoms, and similar overall plasma PHE control over short (3‑week) periods

Clinical roleGMP‑MFs may enhance adherence and tolerability for individuals with PKU but long‑term equivalence to AA‑MFs is limited by short study duration

Crohn Disease Exclusion Diet (CDED)

DefinitionCDED (Crohn Disease Exclusion Diet) is a whole‑food exclusion diet used together with partial enteral nutrition to induce and maintain remission in pediatric Crohn disease

Evidence baseRCT (Levine et al., 2019) compared CDED + partial enteral nutrition vs exclusive enteral nutrition (EEN) and showed higher tolerance and improved sustained corticosteroid‑free remission with CDED + partial enteral nutrition

Program elementsTypical regimen includes staged food exclusion with 50% calories from a formula (stage 1) then reduction to 25% partial enteral nutrition during maintenance stages

Elemental diet / amino acid–based formula

DefinitionElemental diet / amino acid–based formula: an exclusive feeding regimen consisting of amino‑acid based formulas used to induce remission in eosinophilic esophagitis (EoE) and to manage certain severe food‑allergy presentations

Efficacy in EoESystematic review/meta‑analysis reported ~90.8% effectiveness of amino acid–based elemental formulas in inducing remission in EoE (Arias et al., 2014)

Clinical useReserved for induction or refractory cases, severe non‑IgE mediated food allergy, failure of extensively hydrolyzed formula, multiple food eliminations, or when histologic remission is required per guideline recommendations

Medical Food — alternate / reiterated definition

Alternate wording of medical foodA Medical Food is a product formulated for enteral administration under physician supervision for the dietary management of a disease with distinctive nutritional requirements; it must be used under ongoing medical supervision

Reiterated criteriaProduct must be labeled for dietary management of a medical disorder, used under medical supervision, and typically obtained through medical facilities

Coverage implicationFDA definition is informational only; coverage determinations require documentation of medical necessity and adherence to benefit/contractual rules

OpenPayer

Enteral Nutrition (Oral and Tube Feeding)

Coverage Criteria for Enteral Nutrition

Applicable Codes and Assessment Thresholds

Provider Actions, Prior Authorization, and Documentation

Background and Evidence Summary

Definitions

Policy Revision History